{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T15:16:30Z","timestamp":1779203790175,"version":"3.51.4"},"reference-count":38,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,3]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Invasive fungal diseases (IFDs) are opportunistic infections that result in significant morbidity and mortality in pediatric oncology patients. Predictive risk tools for IFD in pediatric cancer are not available.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>We conducted a 7-year retrospective study of pediatric oncology patients with a diagnosis of febrile neutropenia at UCM Comer Children\u2019s Hospitals. Fourteen clinical, laboratory, and treatment-related risk factors for IFD were analyzed. Stepwise variable selection for multiple logistic regression was used to develop a risk prediction model for IFD. Two comparative analyses have been conducted: (i) all suspected IFD cases and (ii) all proven and probable IFD cases.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>A total of 667 febrile neutropenia episodes were identified in 265 patients. IFD was diagnosed in 62 episodes: 13 proven, 27 probable, and 22 possible. In the final multiple logistic regression models, 5 variables were independently significant for both analyses: fever days, neutropenia days, hypotension, and absolute lymphocyte count &lt;250 at the time of diagnosis. The odds ratio and a relative weight for each factor were then calculated and summed to calculate a predictive score. A risk score of \u22644 and \u22645 (10\/11 maximum) for each model signifies low risk, respectively (&lt;1.2% incidence). Model discrimination was evaluated by the area under the receiver operator characteristics curve with an area under the curve of 0.95\/0.94 for each model.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>Our prediction IFD risk models perform well, are easy\u2013to-use, and are based on readily available clinical data. Profound lymphopenia absolute lymphocyte count &lt;250\u2009mm<jats:sup>3<\/jats:sup> could serve as a new important prognostic marker for the development of IFD in pediatric cancer and hematopoietic stem cell transplant patients.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/mph.0000000000002242","type":"journal-article","created":{"date-parts":[[2021,7,5]],"date-time":"2021-07-05T16:16:01Z","timestamp":1625501761000},"page":"e334-e342","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":12,"title":["Pediatric Invasive Fungal Risk Score in Cancer and Hematopoietic Stem Cell Transplantation Patients With Febrile Neutropenia"],"prefix":"10.1097","volume":"44","author":[{"given":"Muayad","family":"Alali","sequence":"first","affiliation":[{"name":"Pediatrics"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mihai","family":"Giurcanu","sequence":"additional","affiliation":[{"name":"Center for Health and the Social Sciences, University of Chicago, Chicago, IL"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lena","family":"Elmuti","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Chicago Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madan","family":"Kumar","sequence":"additional","affiliation":[{"name":"Medicine, Division of Infectious Diseases"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2021,6,30]]},"reference":[{"key":"R1-20250805","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1097\/MPH.0b013e3181864a80","article-title":"The clinical feature of invasive fungal infection in pediatric patients with hematologic and malignant diseases: a 10-year analysis at a single institution at Japan","volume":"30","author":"Kobayashi","year":"2008","journal-title":"J Pediatr Hematol Oncol"},{"key":"R2-20250805","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jmii.2016.08.011","article-title":"Clinical characteristics and outcome of invasive fungal infections in pediatric acute myeloid leukemia patients in a medical center in Taiwan","volume":"51","author":"Lin","year":"2018","journal-title":"J Microbiol Immunol Infect"},{"key":"R3-20250805","doi-asserted-by":"crossref","first-page":"179e1","DOI":"10.1016\/j.cmi.2015.10.017","article-title":"Increased risk of infections and infection-related mortality in children undergoing haematopoietic stem cell transplantation compared to conventional anticancer therapy: a multicentre nationwide study","volume":"22","author":"Styczynski","year":"2016","journal-title":"Clin Microbiol Infect"},{"key":"R4-20250805","doi-asserted-by":"crossref","first-page":"681","DOI":"10.3389\/fmicb.2019.00681","article-title":"Incidence and outcome of invasive fungal diseases in children with hematological malignancies and\/or allogeneic hematopoietic stem cell transplantation: results of a prospective multicenter study","volume":"10","author":"Lehrnbecher","year":"2019","journal-title":"Front Microbiol"},{"key":"R5-20250805","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/00006454-200203000-00013","article-title":"Infections diagnosed in the first year after pediatric stem cell transplantation","volume":"21","author":"Benjamin","year":"2002","journal-title":"Pediatr Infect Dis J"},{"key":"R6-20250805","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1038\/sj.bmt.1705113","article-title":"Risks and outcomes of invasive fungal infections in pediatric patients undergoing allogeneic hematopoietic cell transplantation","volume":"36","author":"Dvorak","year":"2005","journal-title":"Bone Marrow Transplant"},{"key":"R7-20250805","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1097\/INF.0b013e3182737427","article-title":"Results from a prospective, international, epidemiologic study of invasive candidiasis in children and neonates","volume":"31","author":"Steinbach","year":"2012","journal-title":"Pediatr Infect Dis J"},{"key":"R8-20250805","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/0002-9343(84)90665-X","article-title":"Opportunistic fungal infections in patients with neoplastic disease","volume":"76","author":"Gold","year":"1984","journal-title":"Am J Med"},{"key":"R9-20250805","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1200\/JCO.2016.71.7017","article-title":"Guideline for the management of fever and neutropenia in children with cancer and hematopoietic stem-cell transplantation recipients: 2017 update","volume":"35","author":"Lehrnbecher","year":"2017","journal-title":"J Clin Oncol"},{"key":"R10-20250805","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1128\/JCM.01682-16","article-title":"Prospective biomarker screening for diagnosis of invasive aspergillosis in high-risk pediatric patients","volume":"55","author":"Loeffler","year":"2017","journal-title":"J Clin Microbiol"},{"key":"R11-20250805","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1093\/jpids\/pix030","article-title":"Risk factors for invasive fungal disease in pediatric cancer and hematopoietic stem cell transplantation: a systematic review","volume":"7","author":"Fisher","year":"2017","journal-title":"J Pediatric Infect Dis Soc"},{"key":"R12-20250805","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1093\/cid\/ciw592","article-title":"Galactomannan, beta-D-glucan, and polymerase chain reaction-based assays for the diagnosis of invasive fungal disease in pediatric cancer and hematopoietic stem cell transplantation: a systematic review and meta-analysis","volume":"63","author":"Lehrnbecher","year":"2016","journal-title":"Clin Infect Dis"},{"key":"R13-20250805","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1038\/sj.bmt.1702654","article-title":"Invasive fungal infections in pediatric bone marrow transplant recipients: single center experience of 10 years","volume":"26","author":"Hovi","year":"2000","journal-title":"Bone Marrow Transplant"},{"key":"R14-20250805","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/bmt.2013.136","article-title":"Predictors of invasive fungal infection in pediatric allogeneic hematopoietic SCT recipients","volume":"49","author":"Hol","year":"2014","journal-title":"Bone Marrow Transplant"},{"key":"R15-20250805","doi-asserted-by":"crossref","first-page":"b606","DOI":"10.1136\/bmj.b606","article-title":"Prognosis and prognostic research: application and impact of prognostic models in clinical practice","volume":"338","author":"Moons","year":"2009","journal-title":"BMJ"},{"key":"R16-20250805","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1749-6632.2012.06829.x","article-title":"Risk stratification for invasive aspergillosis in immunocompromised patients","volume":"1272","author":"Herbrecht","year":"2012","journal-title":"Ann N Y Acad Sci"},{"key":"R17-20250805","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1093\/cid\/cir073","article-title":"Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of america","volume":"52","author":"Freifeld","year":"2011","journal-title":"Clin Infect Dis"},{"key":"R18-20250805","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1086\/588660","article-title":"Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer\/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC\/MSG) Consensus Group","volume":"46","author":"De Pauw","year":"2008","journal-title":"Clin Infect Dis"},{"key":"R19-20250805","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1164\/rccm.200805-737OC","article-title":"Randomized controlled trial of oral antifungal treatment for severe asthma with fungal sensitization: The Fungal Asthma Sensitization Trial (FAST) study","volume":"179","author":"Denning","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"R20-20250805","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1086\/522533","article-title":"A prospective study on the epidemiology of febrile episodes during chemotherapy-induced neutropenia in children with cancer or after hemopoietic stem cell transplantation","volume":"45","author":"Castagnola","year":"2007","journal-title":"Clin Infect Dis"},{"key":"R21-20250805","doi-asserted-by":"crossref","first-page":"3781","DOI":"10.1002\/cncr.30792","article-title":"Multisite external validation of a risk prediction model for the diagnosis of blood stream infections in febrile pediatric oncology patients without severe neutropenia","volume":"123","author":"Esbenshade","year":"2017","journal-title":"Cancer"},{"key":"R22-20250805","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/INF.0b013e3181c3f6f0","article-title":"Risk prediction in pediatric cancer patients with fever and neutropenia","volume":"29","author":"Hakim","year":"2010","journal-title":"Pediatr Infect Dis J"},{"key":"R23-20250805","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1093\/jpids\/pix030","article-title":"Risk factors for invasive fungal disease in pediatric cancer and hematopoietic stem cell transplantation: a systematic review","volume":"7","author":"Fisher","year":"2018","journal-title":"J Pediatric Infect Dis Soc"},{"key":"R24-20250805","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1097\/MPH.0b013e318142b598","article-title":"Evaluation of risk factors for invasive fungal infection after allogeneic stem cell transplantation in pediatric patients","volume":"29","author":"Kobayashi","year":"2007","journal-title":"J Pediatr Hematol Oncol"},{"key":"R25-20250805","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1097\/INF.0b013e3181e7db7f","article-title":"Risk factors associated with invasive fungal disease in children with cancer and febrile neutropenia: a prospective multicenter evaluation","volume":"29","author":"Villarroel","year":"2010","journal-title":"Pediatr Infect Dis J"},{"key":"R26-20250805","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1111\/myc.12063","article-title":"Invasive fungal infections in paediatric acute myeloid leukaemia","volume":"56","author":"Johnston","year":"2013","journal-title":"Mycoses"},{"key":"R27-20250805","first-page":"174","article-title":"Invasive fungal infection in children with persistent febrile neutropenia","volume":"104","author":"Lai","year":"2005","journal-title":"J Formos Med Assoc"},{"key":"R28-20250805","doi-asserted-by":"crossref","first-page":"345","DOI":"10.7326\/0003-4819-100-3-345","article-title":"Prolonged granulocytopenia: the major risk factor for invasive pulmonary aspergillosis in patients with acute leukemia","volume":"100","author":"Gerson","year":"1984","journal-title":"Ann Intern Med"},{"key":"R29-20250805","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1086\/591969","article-title":"Epidemiology of invasive mold infections in allogeneic stem cell transplant recipients: biological risk factors for infection according to time after transplantation","volume":"47","author":"Garcia-Vidal","year":"2008","journal-title":"Clin Infect Dis"},{"key":"R30-20250805","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1182\/blood.V82.5.1672.bloodjournal8251672","article-title":"Lymphocytopenia as an unfavorable prognostic factor in patients with cytomegalovirus infection after bone marrow transplantation","volume":"82","author":"Einsele","year":"1993","journal-title":"Blood"},{"key":"R31-20250805","doi-asserted-by":"crossref","first-page":"5711","DOI":"10.1182\/blood-2008-10-143560","article-title":"How we treat cytomegalovirus in hematopoietic cell transplant recipients","volume":"113","author":"Boeckh","year":"2009","journal-title":"Blood"},{"key":"R32-20250805","doi-asserted-by":"crossref","first-page":"5476","DOI":"10.1182\/blood-2010-04-259291","article-title":"How I treat adenovirus in hematopoietic stem cell transplant recipients","volume":"116","author":"Lindemans","year":"2010","journal-title":"Blood"},{"key":"R33-20250805","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1016\/j.bbmt.2010.07.021","article-title":"D-index and prediction of infection","volume":"16","author":"Portugal","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"key":"R34-20250805","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/j.1365-2141.2009.08072.x","article-title":"Epidemiology of paediatric invasive fungal infections and a case-control study of risk factors in acute leukaemia or post stem cell transplant","volume":"149","author":"Hale","year":"2010","journal-title":"Br J Haematol"},{"key":"R35-20250805","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.bbmt.2012.08.012","article-title":"Timeline, epidemiology, and risk factors for bacterial, fungal, and viral infections in children and adolescents after allogeneic hematopoietic stem cell transplantation","volume":"19","author":"Srinivasan","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"key":"R36-20250805","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/INF.0000000000000101","article-title":"Role of management strategies in reducing mortality from invasive fungal disease in children with cancer or receiving hemopoietic stem cell transplant: a single center 30-year experience","volume":"33","author":"Castagnola","year":"2014","journal-title":"Pediatr Infect Dis J"},{"key":"R37-20250805","doi-asserted-by":"crossref","first-page":"205","DOI":"10.7326\/0003-4819-123-3-199508010-00008","article-title":"Antimicrobial prophylaxis in bone marrow transplantation","volume":"123","author":"Momin","year":"1995","journal-title":"Ann Intern Med"},{"key":"R38-20250805","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/j.bbmt.2014.03.026","article-title":"Role of acute graft-versus-host disease in the risk of bacteremia and invasive fungal disease after allogeneic hemopoietic stem cell transplantation in children. Results from a single-center observational study","volume":"20","author":"Castagnola","year":"2014","journal-title":"Biol Blood Marrow Transplant"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000002242","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T01:00:23Z","timestamp":1754355623000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000002242"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,30]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0000000000002242","relation":{},"ISSN":["1077-4114"],"issn-type":[{"value":"1077-4114","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6,30]]},"assertion":[{"value":"2021-01-23","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-05-21","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}